Buscar resultados de ensayos clínicos
Familial Primary Pulmonary Hypertension - 25 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: ADAPT - A Patient Registry of the Real-world Use of Orenitram® Condición: Pulmonary Arterial Hypertension Fecha: 2017-02-02 Intervenciones: Drug: Oral treprostinil Sustained-release oral tablets for TID administration |
Withdrawn |
Nombre del estudio: Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH Condición: Pulmonary Arterial Hypertension Fecha: 2017-01-06 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension Condición: Pulmonary Arterial Hypertension Fecha: 2016-12-19 Intervenciones:
|
Recruiting |
Nombre del estudio: Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA) Condición: Pulmonary Arterial Hypertension Fecha: 2016-11-14 Intervenciones:
|
Recruiting |
Nombre del estudio: The Effect of Adding Exercise Training to Optimal Therapy in PAH Condición: Pulmonary Arterial Hypertension Fecha: 2016-11-08 Intervenciones: Other: Exercise therapy 3-week residential phase and 12-we |
Recruiting |
Nombre del estudio: Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies Condición: Idiopathic Pulmonary Arterial Hypertension Fecha: 2015-04-23 |
Withdrawn |
Nombre del estudio: FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan Condición: Pulmonary Arterial Hypertension Fecha: 2015-04-06 Intervenciones: Other: CT imaging, functional PET imaging Physiology study using CT and functional PET imaging with 13NN |
Not yet recruiting |
Nombre del estudio: Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients Condición: Pulmonary Arterial Hypertension (PAH) Fecha: 2016-10-12 Intervenciones: Drug: QCC374 |
Not yet recruiting |
Nombre del estudio: A Study to Find Out Whether the Medicine Macitentan Works in Children With Pulmonary Arterial Hypertension (PAH) Condición: Pulmonary Arterial Hypertension Fecha: 2016-10-12 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients Condición: Pulmonary Arterial Hypertension (PAH) Fecha: 2016-10-05 Intervenciones:
|